Evidence map›Paper›PMID 38872952›Full record

ArticleBMC methods2024

Mini-MEndR: a miniaturized 96-well predictive assay to evaluate muscle stem cell-mediated repair.

Nitya Gulati, Sadegh Davoudi, Bin Xu, Saifedine T Rjaibi, Erik Jacques, Justin Pham, Amir Fard, Alison P McGuigan, Penney M Gilbert

Abstract read
In one paragraph

Article in BMC methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nitya Gulati *Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S3E4 Canada.
Sadegh Davoudi *Donnelly Centre, University of Toronto, Toronto, ON M5S3E1 Canada.
Bin Xu *Donnelly Centre, University of Toronto, Toronto, ON M5S3E1 Canada.
Saifedine T Rjaibi *Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S3E4 Canada.
Erik Jacques *Donnelly Centre, University of Toronto, Toronto, ON M5S3E1 Canada.
Justin PhamDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S3E4 Canada.
Amir FardDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S3E4 Canada.
Alison P McGuiganDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S3E4 Canada.
Penney M GilbertDonnelly Centre, University of Toronto, Toronto, ON M5S3E1 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Functional evaluation of molecules that are predicted to promote stem cell mediated endogenous repair often requires in vivo transplant studies that are low throughput and hinder the rate of discovery. To offer greater throughput for functional validation studies, we miniaturized, simplified and expanded the functionality of a previously developed muscle endogenous repair (MEndR) in vitro assay that was shown to capture significant events of in vivo muscle endogenous repair. Methods: The mini-MEndR assay consists of miniaturized cellulose scaffolds designed to fit in 96-well plates, the pores of which are infiltrated with human myoblasts encapsulated in a fibrin-based hydrogel to form engineered skeletal muscle tissues. Pre-adsorbing thrombin to the cellulose scaffolds facilitates in situ tissue polymerization, a critical modification that enables new users to rapidly acquire assay expertise. Following the generation of the 3D myotube template, muscle stem cells (MuSCs), enriched from digested mouse skeletal muscle tissue using an improved magnetic-activated cell sorting protocol, are engrafted within the engineered template. Murine MuSCs are fluorescently labeled, enabling co-evaluation of human and mouse Pax7 Results: The miniaturized format and modified manufacturing protocol cuts reagent costs in half and hands-on seeding time ~ threefold, while the image analysis pipelines save 40 h of labour. By evaluating multiple commercially available human primary myoblast lines in 2D and 3D culture, we establish quality assurance metrics for cell line selection that standardizes myotube template quality. In vivo outcomes (enhanced muscle production and Pax7 Discussion: The miniaturized predictive assay offers a simple, scaled platform to co-investigate human and mouse skeletal muscle endogenous repair molecular modulators, and thus is a promising strategy to accelerate the muscle endogenous repair discovery pipeline. Supplementary Information: The online version contains supplementary material available at 10.1186/s44330-024-00005-4.

Indexed as

Endogenous repairManufacturingPredictive assayScale-upSkeletal muscleStem cell

Identifiers

PMID38872952
PMCPMC11173370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.